BioCentury | Jan 11, 2019
Financial News
New exchange may give biotechs alternative to NASDAQ, NYSE
A new equities exchange founded by financial firms could offer biotechs a simple, low-cost alternative to NASDAQ or NYSE. The Members Exchange (MEMX), which counts BofA Merrill Lynch and Morgan Stanley among its founders, will...